| USD ($) $ in Millions | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 |
|---|---|---|---|
Revenue | $ 4,920 | $ 4,007 | $ 3,233 |
Cost of sales | 121 | 121 | 154 |
Gross profit (loss) | 4,799 | 3,886 | 3,079 |
Research and development | 2,776 | 2,071 | 1,979 |
Selling, general and administrative | 1,115 | 984 | 983 |
Impairment of long-lived assets | - | - | 0 |
Disposal, restructuring and other operating expenses, net | 8 | 0 | 6 |
Total operating expenses | 3,899 | 3,055 | 2,968 |
Operating income (loss) | 900 | 831 | 111 |
Income (loss) from equity investments, net | 14 | (237) | (20) |
Interest income, net | 111 | 116 | 110 |
Other non-operating income (loss), net | 132 | 10 | 11 |
Income (loss) before income taxes | 1,157 | 720 | 212 |
Income tax benefit (expense) | 253 | (72) | (94) |
Net income (loss) from continuing operations | - | - | 306 |
Loss from discontinued operations before income taxes | - | - | 0 |
Income tax benefit (expense) from discontinued operations | - | - | 0 |
Net loss from discontinued operations | - | - | 0 |
Net income (loss) | $ 904 | $ 792 | $ 306 |
Net income (loss) per share attributable to ordinary shareholders | |||
Basic (in USD per share) | $ 0.85 | $ 0.75 | $ 0.3 |
Net loss from discontinued operation (in USD per share) | - | - | 0 |
Net income (loss) per share - basic (in USD per share) | - | - | 0.3 |
Net income (loss) per share attributable to ordinary shareholders – diluted | |||
Diluted (in USD per share) | 0.85 | 0.75 | 0.29 |
Net loss from discontinued operation (in USD per share) | - | - | 0 |
Net income (loss) per share - diluted (in USD per share) | - | - | $ 0.29 |
Weighted average ordinary shares outstanding | |||
Basic (in shares) | 1,061,000,000 | 1,050,000,000 | 1,027,443,122 |
Diluted (in shares) | 1,068,000,000 | 1,063,000,000 | 1,044,497,032 |